Microfluidics Market to reach USD 92.43 billion by 2032, growing at a CAGR of 14.29%
The microfluidics market is growing rapidly due to the increased need for fast, low-cost diagnostic tools and precision healthcare solutions. Microfluidic devices, for example, lab-on-a-chip and point-of-care testing systems are most critical to making rapid diagnostics that cater to a U.S. Diagnostic & Medical Laboratories market worth USD 79.4 billion in 2023 alone. With more than 5,500 pharmaceutical companies actively conducting R&D worldwide, microfluidics-based technologies help in scalable health solutions. Microfluidics offers maximum efficiency in biochemical analyses for complex analyses with small samples, thus fueling clinical diagnostics and research growth.